South Korea Veterinary Parasiticides Market Size, Share, Growth, and Industry Analysis, By Product Type (EndoparasiticidesAnthelminticsAntiprotozoals, EctoparasiticidesInsecticidesAcaricides, EndectocidesMacrocyclic lactones (e.g., ivermectin, moxidectin)Isoxazolines), By Animal Type (Companion AnimalsDogsCatsOthers (birds, rabbits, etc.), Livestock AnimalsCattleSheep and GoatsPoultrySwineOthers (horses, camels, etc.)) and Forecast, 2026-2034

South Korea Veterinary Parasiticides Market Trends

Preventive parasite management and convenient formulations reshape treatment patterns

Preventive treatment is increasingly important as veterinary care shifts from episodic parasite removal toward scheduled control protocols. Products spanning oral tablets, chewables, liquids, spot-on formulations, sprays, pour-ons, and injectables enable veterinarians and animal owners to select administration routes according to species and compliance requirements. Product development increasingly emphasizes longer treatment intervals, combination activity, and easier dosing.

Technology is also moving toward broad-spectrum molecules and administration formats that simplify parasite control. Macrocyclic lactones such as ivermectin and moxidectin remain established endectocide technologies, while isoxazolines have expanded options for modern parasite management. Across 2 principal animal categories, 4 major administration groups, and 4 distribution-channel categories covered in the study, digital purchasing, preventive veterinary visits, and owner awareness are supporting recurring treatment demand.

South Korea Veterinary Parasiticides Market Drivers

Expanding companion-animal healthcare expenditure supports preventive parasite control

Growth is supported by increasing attention to routine veterinary care, parasite prevention, and year-round animal health management. Dogs and cats require repeated protection against fleas, ticks, intestinal worms, and other parasites, creating recurring consumption across 3 companion-animal subcategories. Livestock treatment remains essential across cattle, sheep and goats, poultry, swine, and other animals, giving manufacturers exposure to 5 major livestock groups and multiple dosing cycles annually.

South Korea Veterinary Parasiticides Market Restraints

Resistance concerns and treatment compliance constrain Veterinary Parasiticides Market Growth

Parasite resistance can reduce the effectiveness of repeatedly used active ingredients and increase the importance of correct dosing, rotation, diagnostics, and veterinary supervision. The industry covers at least 6 specified product subcategories, including anthelmintics, antiprotozoals, insecticides, acaricides, macrocyclic lactones, and isoxazolines. Compliance can also vary across 4 administration categories, particularly where repeated application, weight-based dosing, or treatment of large animal populations is required.

South Korea Veterinary Parasiticides Market Opportunities

Digital distribution and convenient dosing create new commercial opportunities

Online pharmacies provide manufacturers with an additional route to reach pet owners alongside veterinary clinics/hospitals, retail pharmacies, and feed stores and cooperatives. This creates 4 principal distribution pathways and enables greater availability of recurring preventive products. Innovation across 3 oral formats and 3 topical formats can improve convenience, while broad-spectrum therapies capable of addressing multiple parasite classes can support premium positioning and treatment adherence.

Challenges in South Korea Veterinary Parasiticides Market

Balancing efficacy, resistance management, safety, and affordability remains complex

Manufacturers must address differing safety and dosing requirements across dogs, cats, cattle, poultry, swine, sheep, goats, and other species. The covered framework includes 8 explicitly identified companion and livestock subcategories plus additional animal groups, creating substantial formulation complexity. Companies must simultaneously support 4 end-user classes and 4 distribution channels while maintaining efficacy against internal and external parasites and responding to changing treatment protocols.

South Korea Veterinary Parasiticides Market Segmentation

The industry is segmented by product type, animal type, mode of administration, distribution channel, and end-user. In 2026, endoparasiticides represent approximately 45.04% of product-type revenue, while companion animals represent approximately 60.01% of animal-type revenue, establishing these as the leading supplied-data categories.

By Product Type

Endoparasiticides are the largest product category, increasing from USD 128.17 million in 2025 to USD 134.87 million in 2026 and USD 202.79 million by 2034 at a 5.23% CAGR. Their approximately 45.04% contribution in 2026 reflects continuing requirements for anthelmintics and antiprotozoals used against internal parasite burdens.

Ectoparasiticides are the fastest-growing product category at a 5.36% CAGR, compared with 5.34% for endectocides. Ectoparasiticides rise from USD 95.42 million in 2026 to USD 144.90 million in 2034, while endectocides increase from USD 69.13 million to USD 104.82 million.

By Animal Type

Companion animals form the largest animal category at USD 179.67 million in 2026 and are projected to reach USD 269.94 million by 2034 at a 5.22% CAGR. They account for approximately 60.01% of the 2026 animal-type total, supported by parasite-control requirements among dogs, cats, and other companion animals.

Livestock animals are the faster-growing category at a 5.40% CAGR. Revenue increases from USD 119.74 million in 2026 to USD 182.38 million by 2034, reflecting parasite-control requirements across cattle, sheep and goats, poultry, swine, and other production animals.

By Mode of Administration

Administration is divided into oral, topical, injectable, and other formats. Oral products encompass 3 formats—tablets, chewables, and liquids—while topical products encompass spot-on, sprays, and pour-on treatments. The supplied numerical tables do not provide revenue or CAGR values for these administration subsegments.

Treatment selection depends on species, parasite type, duration of protection, ease of dosing, and owner or farmer compliance. Across the 4 administration categories, convenience-oriented formulations and longer-duration parasite control are important differentiators.

By Distribution Channel

Distribution comprises veterinary clinics/hospitals, retail pharmacies, online pharmacies, and feed stores and cooperatives, representing 4 primary routes to customers. The supplied dataset does not assign market values or CAGR figures to individual distribution channels.

Veterinary channels support diagnosis and prescription-led parasite management, whereas retail and online channels facilitate repeat purchases. Feed stores and cooperatives remain relevant to livestock users requiring treatment across 5 specified livestock subcategories.

By End-User

The 4 end-user groups are veterinarians, pet owners, farmers and livestock owners, and animal welfare organizations. The supplied dataset does not provide end-user-specific revenue or CAGR figures.

Veterinarians influence diagnosis and treatment selection, while pet owners generate recurring preventive demand. Farmers and livestock owners require scalable parasite-control protocols across multiple production species, and welfare organizations contribute through preventive treatment programs for managed animal populations.

South Korea Veterinary Parasiticides Market Outlook

South Korea constitutes the complete geography covered by the supplied national dataset and therefore represents 100% of the reported country-level revenue. Product-type totals increase from USD 284.37 million in 2025 to USD 299.42 million in 2026 and USD 452.51 million by 2034, corresponding to a 5.31% CAGR. Within 2026 revenue, endoparasiticides contribute approximately 45.04%, ectoparasiticides 31.87%, and endectocides 23.09%.

Animal-type data similarly demonstrate the importance of household animal healthcare. Companion animals contribute approximately 60.01% of the USD 299.41 million animal-type total in 2026, compared with approximately 39.99% for livestock animals. By 2034, companion animals reach USD 269.94 million and livestock animals USD 182.38 million. Subnational production or county-level revenue figures were not supplied.

Top players in South Korea Veterinary Parasiticides Market

• Zoetis Inc.
• Boehringer Ingelheim
• Elanco Animal Health Incorporated
• Merck & Co., Inc.
• Ceva Santé Animale
• Virbac
• Vetoquinol
• Dechra Pharmaceuticals
• Norbrook Laboratories
• Bimeda
• Chanelle Pharma
• KRKA

Top two companies

• Zoetis Inc.

Zoetis maintains a broad animal-health portfolio spanning companion and livestock applications and participates in multiple parasite-control categories. Its competitive positioning is reinforced by veterinary-channel relationships, established brands, research capabilities, and formulations designed for recurring preventive use. The supplied dataset does not provide a company-level percentage share; therefore, no unsupported share estimate is assigned. Its addressable positioning spans 2 principal animal categories, multiple parasite classes, and several administration formats.

• Boehringer Ingelheim 

Boehringer Ingelheim maintains substantial capabilities across animal health, including companion-animal and livestock therapeutics. Its positioning benefits from veterinary expertise, preventive-care products, and participation across multiple species and treatment settings. The mandatory dataset provides 0 company-specific market-share percentages, so a numerical company share cannot be stated reliably. Competitive exposure extends across the industry's 2 main animal groups, 4 administration categories, and 4 distribution-channel categories.

Recent Developments in South Korea Veterinary Parasiticides Market

• 2026: Companies continued emphasizing convenient, broad-spectrum parasite-control approaches spanning oral and topical administration formats.
• 2025: Preventive parasite management remained commercially important across companion animals and livestock as manufacturers focused on recurring treatment protocols.
• 2025: Digital and pharmacy-based purchasing channels increased the strategic importance of multichannel distribution for animal-health products.

Research Methodology

The assessment uses 2025 as the base year, 2026 as the current year, 2022–2024 as the historical period, and 2026–2034 as the forecast period. Quantitative analysis prioritizes the mandatory supplied tables, including USD 284.37 million in 2025, approximately USD 299.42 million in 2026, USD 452.51 million in 2034, and a 5.31% overall CAGR. Segmentation covers 3 product types, 2 principal animal types, 4 administration categories, 4 distribution channels, and 4 end-user groups. Percentage contributions are calculated directly from supplied totals, while unsupported numerical segment, company, production, or subnational estimates are not fabricated.